Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma

NCT03927157 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

405

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

BIOLOGICAL: Experimental: Tezepelumab
OTHER: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]